Application Nr Approved Date Route Status External Links
ANDA090094 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Didanosine Delayed-Release Capsules, Also Known As Ddi, In Combination With Other Antiretroviral Agents Are Indicated For The Treatment Of Human Immunodeficiency Virus (Hiv)-1 Infection [See Clinical Studies (14) ] . Didanosine Delayed-Release Capsules Are A Nucleoside Reverse Transcriptase Inhibitor For Use In Combination With Other Antiretroviral Agents For The Treatment Of Human Immunodeficiency Virus (Hiv)-1 Infection. (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Didanosine DIDANOSINE ZINC13597823

Comments